Golimumab.
Pappas
Dimitrios A
DA
Bathon
Joan M
JM
Hanicq
Delphine
D
Yasothan
Uma
U
Kirkpatrick
Peter
P
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D000079424:Tumor Necrosis Factor Inhibitors; D048069:Tumor Necrosis Factors / Q000276:immunology
D000911:Antibodies, Monoclonal; D000079424:Tumor Necrosis Factor Inhibitors; D048069:Tumor Necrosis Factors; C529000:golimumab; D008727:Methotrexate